ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could help men regrow hair
Disease control OngoingThis study tests an investigational oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18-65 with mild to moderate hair loss will take either the drug or a placebo for 6 months, then all will receive the active drug for another 6 months…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2, PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New pill could help regrow hair in both men and women
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for people with mild to moderate pattern baldness (androgenetic alopecia). About 70 men and women aged 18-65 will take a daily tablet for 12 months. Researchers will measure hair regrowth using digital imaging and ask part…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New pill could fight baldness: phase 3 trial underway
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take the drug or a placebo daily for 6 months. Researchers will measure changes in hair count and ask part…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 19, 2026 11:59 UTC